Ever Supreme Bio Technology Co., Ltd (TPEX:6712)

TPEX:6712 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	441.69	222.16	301.68	336.44	353.57	641.1
Short-Term Investments	407.5	213.5	636.5	998.6	915.99	702.6
Cash & Short-Term Investments	849.19	435.66	938.18	1,335	1,270	1,344
Cash Growth	139.53%	-53.56%	-29.73%	5.16%	-5.52%	223.80%
Accounts Receivable	194.91	229.47	193.99	100.63	84.94	33.66
Other Receivables	5.3	7.73	7.56	0.46	0.88	29.6
Receivables	200.21	237.19	201.54	101.09	85.82	63.27
Inventory	91.93	75.71	80.04	69.09	88.3	56.77
Prepaid Expenses	13.19	3.3	3.44	7.92	6.29	2.11
Other Current Assets	3.54	0.83	0.06	7.73	5.46	0.92
Total Current Assets	1,158	752.68	1,223	1,521	1,455	1,467
Property, Plant & Equipment	58.31	74.68	48.58	64.81	89.84	125.01
Long-Term Investments	1,026	1,062	796.16	471.31	376.37	333.27
Other Intangible Assets	1,098	13.39	10.15	10.65	11.95	11.14
Long-Term Deferred Tax Assets	11.76	10.98	10.73	1.71	30.32	78.2
Other Long-Term Assets	60.65	90.27	47.24	6.57	9.72	8.22
Total Assets	3,413	2,004	2,136	2,076	1,974	2,023

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	32.91	43.41	25.13	23.33	29.08	15
Accrued Expenses	-	1.61	2.4	1.96	3.98	10.49
Current Portion of Leases	9.27	10.38	1.71	5.4	4.5	11.87
Current Income Taxes Payable	46.47	45.89	68.07	46.76	10.47	21.04
Current Unearned Revenue	330.12	290.98	194.13	121.65	89.89	12.22
Other Current Liabilities	40.73	30.28	37.66	32.55	25.82	25.9
Total Current Liabilities	459.49	422.55	329.09	231.64	163.74	96.51
Long-Term Leases	20.75	28.37	1.14	0.5	13.36	22.55
Long-Term Deferred Tax Liabilities	8.14	8.57	10.82	-	3.59	3.82
Other Long-Term Liabilities	11.07	18.32	0.78	0.82	0.76	1.96
Total Liabilities	499.44	477.8	341.82	232.96	181.45	124.83

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,005	875.97	806.73	733.39	681.4	618.18
Additional Paid-In Capital	1,633	509.31	551.72	785.91	872.22	1,211
Retained Earnings	318.14	218.3	434.23	323.67	238.51	68.74
Comprehensive Income & Other	-42.35	-77.03	1.6	-	0.04	-
Shareholders' Equity	2,913	1,527	1,794	1,843	1,792	1,898
Total Liabilities & Equity	3,413	2,004	2,136	2,076	1,974	2,023

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	30.02	38.75	2.84	5.9	17.86	34.42
Net Cash (Debt)	819.18	396.91	935.33	1,329	1,252	1,309
Net Cash Growth	161.62%	-57.56%	-29.63%	6.19%	-4.40%	252.17%
Net Cash Per Share	8.31	4.30	10.03	14.02	13.07	13.69
Filing Date Shares Outstanding	100.36	91.98	93.18	93.18	95.2	95
Total Common Shares Outstanding	100.36	91.98	93.18	93.18	95.2	95
Working Capital	698.58	330.14	894.16	1,289	1,292	1,370
Book Value Per Share	29.03	16.60	19.26	19.78	18.83	19.98
Tangible Book Value	1,815	1,513	1,784	1,832	1,780	1,887
Tangible Book Value Per Share	18.08	16.45	19.15	19.66	18.70	19.86
Machinery	-	94.91	93.5	91.2	85.39	82.64
Leasehold Improvements	-	63.28	63.28	65.23	65.23	63.9

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error